Related Experiment Video
Updated: Jul 25, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Long noncoding RNA MIAT regulates TP53 ubiquitination and expedites prostate adenocarcinoma progression by recruiting
Zheng Gong1, Huijing Zhang2, Yuntian Ge1
1Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning, PR China.
Abstract:
Despite recent advances in cancer immunotherapy, their efficacy for treating patients with prostate adenocarcinoma (PRAD) is low due to complex immune evasion mechanisms. However, the function of long non-coding RNA (lncRNAs) in immune evasion has not been fully clarified. This study aimed to expound the role of myocardial infarction-associated transcript (MIAT), a lncRNA significantly upregulated in three PRAD-associated datasets, in immune evasion and try to reveal the potential mechanism. MIAT was highly expressed in PRAD tissues and predicted poor prognosis, and suppression of MIAT inhibited the malignant biological behavior of PRAD cells. Moreover, the depletion of MIAT promoted the immune response of CD8+ T cells and hampered the immune evasion of PRAD cells. In addition, MIAT downregulated TP53 protein expression by recruiting transducin beta-like protein 1X (TBL1X) for ubiquitination modification. Silencing of TP53 or overexpression of TBL1X was enough to abate the tumor suppressive effects of MIAT knockdown in vitro and in vivo. Our results provide evidence for a novel regulation mechanism of CD8+ T cells in PRAD and MIAT may serve as a potential therapeutic target in PRAD.
Insights
Myocardial infarction-associated transcript (MIAT) promotes immune evasion in prostate adenocarcinoma (PRAD) by downregulating TP53. Suppressing MIAT enhances CD8+ T cell response, offering a potential therapeutic target for PRAD.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Cancer immunotherapy efficacy is limited in prostate adenocarcinoma (PRAD) due to immune evasion.
- The role of long non-coding RNAs (lncRNAs) in PRAD immune evasion remains unclear.
Purpose of the Study:
- To investigate the role of myocardial infarction-associated transcript (MIAT) in PRAD immune evasion.
- To elucidate the underlying molecular mechanism of MIAT in PRAD.
Main Methods:
- Analysis of MIAT expression in PRAD datasets and tissues.
- In vitro and in vivo experiments involving MIAT knockdown and TP53/TBL1X manipulation.
- Investigation of MIAT's interaction with transducin beta-like protein 1X (TBL1X) and its effect on TP53 ubiquitination.
Main Results:
- MIAT is highly expressed in PRAD, correlating with poor prognosis and promoting malignant behavior.
- MIAT depletion enhances CD8+ T cell response and reduces PRAD immune evasion.
- MIAT downregulates TP53 by recruiting TBL1X for ubiquitination, a process critical for MIAT's oncogenic function.
Conclusions:
- MIAT plays a significant role in PRAD immune evasion through the TBL1X/TP53 pathway.
- Targeting MIAT presents a promising therapeutic strategy for enhancing anti-tumor immunity in PRAD.
More Related Videos
Related Concept Videos
MicroRNAs
Abnormal Proliferation
lncRNA - Long Non-coding RNAs
RNA Stability
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
piRNA - Piwi-interacting RNAs

